NEOG.NASDAQNeogen CORP

Form 4: NEOGEN Director Boosts Stake with Stock & Options

Sentiment:

Insider Transaction Report


NEOGEN Director Andrea F Wainer acquired 19,769 shares of common stock and 50,814 derivative securities, signaling increased insider ownership.

Summary

  • Andrea F Wainer, a Director of NEOGEN CORP (NEOG), acquired 19,769 shares of common stock.
  • The common stock was acquired at a price of $6.07 per share.
  • Additionally, 50,814 derivative securities, specifically a 'Right to Buy' Common Stock, were acquired.
  • These derivative securities have an exercise price of $6.07 per share and an expiration date of October 23, 2035.
  • Both the common stock and derivative securities transactions occurred on October 23, 2025.
  • The acquired options and Restricted Stock Units (RSUs) will vest in equal annual installments over the first three anniversary dates of the grants.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director increasing their stake in the company, which typically signals confidence in future performance and aligns management interests with shareholders.

Positives

  • Increased insider ownership by a Director, Andrea F Wainer, which often signals confidence in the company's future prospects.
  • The acquisition of both direct common stock and derivative securities aligns the director's interests more closely with those of shareholders.

Future Outlook

The acquired options and RSUs are subject to a vesting schedule, with equal annual installments vesting on each of the first three anniversary dates of the grants, starting from October 23, 2025.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends. It reflects a specific director's investment decision within the company.

Related Party Transactions

  • Andrea F Wainer, a Director of NEOGEN CORP, acquired 19,769 shares of common stock and 50,814 derivative securities from the issuer. This constitutes a related party transaction as it involves a company insider.

Stakeholder Impact

  • Shareholders: The increased stake by a director may be viewed positively, suggesting management's belief in the company's value and future growth, potentially boosting investor confidence.
  • Management: The vesting schedule for the acquired securities incentivizes long-term performance and alignment with company goals.

Next Steps

  • Vesting of options and RSUs in equal annual installments on the first three anniversary dates of the grants, starting October 23, 2025.

Key Dates

DateDescription
10/23/2025Transaction date for the acquisition of 19,769 shares of Common Stock and 50,814 derivative securities.
10/23/2026First anniversary of the grant date, when a portion of the options and RSUs will vest.
10/23/2027Second anniversary of the grant date, when a portion of the options and RSUs will vest.
10/23/2028Third anniversary of the grant date, when the final portion of the options and RSUs will vest.
10/23/2035Expiration date for the acquired derivative securities (Right to Buy Common Stock).

Recommendation

buy

Insider buying, especially by a director, is generally considered a strong positive signal. It indicates that those with the most intimate knowledge of the company believe its stock is undervalued or has significant upside potential. This increased alignment of interests between management and shareholders can instill greater confidence in the company's future performance.

Keywords

NEOGEN, NEOG, Insider Transaction, Form 4, Stock Acquisition, Director, Beneficial Ownership, Derivative Securities

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.